INTRODUCTION: We performed a whole-transcriptome correlation analysis, followed by the pathway enrichment and testing of innate immune response pathway analyses to evaluate the hypothesis that transcriptional activity can predict cortical gray matter thickness (GMT) variability during normal cerebral aging. METHODS: Transcriptome and GMT data were available for 379 individuals (age range=28-85) community-dwelling members of large extended Mexican American families. Collection of transcriptome data preceded that of neuroimaging data by 17 years. Genome-wide gene transcriptome data consisted of 20,413 heritable lymphocytes-based transcripts. GMT measurements were performed from high-resolution (isotropic 800 μm) T1-weighted MRI. Transcriptome-wide and pathway enrichment analysis was used to classify genes correlated with GMT. Transcripts for sixty genes from seven innate immune pathways were tested as specific predictors of GMT variability. RESULTS: Transcripts for eight genes (IGFBP3, LRRN3, CRIP2, SCD, IDS, TCF4, GATA3, and HN1) passed the transcriptome-wide significance threshold. Four orthogonal factors extracted from this set predicted 31.9% of the variability in the whole-brain and between 23.4 and 35% of regional GMT measurements. Pathway enrichment analysis identified six functional categories including cellular proliferation, aggregation, differentiation, viral infection, and metabolism. The integrin signaling pathway was significantly (p<10(-6)) enriched with GMT. Finally, three innate immune pathways (complement signaling, toll-receptors and scavenger and immunoglobulins) were significantly associated with GMT. CONCLUSION: Expression activity for the genes that regulate cellular proliferation, adhesion, differentiation and inflammation can explain a significant proportion of individual variability in cortical GMT. Our findings suggest that normal cerebral aging is the product of a progressive decline in regenerative capacity and increased neuroinflammation.
INTRODUCTION: We performed a whole-transcriptome correlation analysis, followed by the pathway enrichment and testing of innate immune response pathway analyses to evaluate the hypothesis that transcriptional activity can predict cortical gray matter thickness (GMT) variability during normal cerebral aging. METHODS: Transcriptome and GMT data were available for 379 individuals (age range=28-85) community-dwelling members of large extended Mexican American families. Collection of transcriptome data preceded that of neuroimaging data by 17 years. Genome-wide gene transcriptome data consisted of 20,413 heritable lymphocytes-based transcripts. GMT measurements were performed from high-resolution (isotropic 800 μm) T1-weighted MRI. Transcriptome-wide and pathway enrichment analysis was used to classify genes correlated with GMT. Transcripts for sixty genes from seven innate immune pathways were tested as specific predictors of GMT variability. RESULTS: Transcripts for eight genes (IGFBP3, LRRN3, CRIP2, SCD, IDS, TCF4, GATA3, and HN1) passed the transcriptome-wide significance threshold. Four orthogonal factors extracted from this set predicted 31.9% of the variability in the whole-brain and between 23.4 and 35% of regional GMT measurements. Pathway enrichment analysis identified six functional categories including cellular proliferation, aggregation, differentiation, viral infection, and metabolism. The integrin signaling pathway was significantly (p<10(-6)) enriched with GMT. Finally, three innate immune pathways (complement signaling, toll-receptors and scavenger and immunoglobulins) were significantly associated with GMT. CONCLUSION: Expression activity for the genes that regulate cellular proliferation, adhesion, differentiation and inflammation can explain a significant proportion of individual variability in cortical GMT. Our findings suggest that normal cerebral aging is the product of a progressive decline in regenerative capacity and increased neuroinflammation.
Authors: Peter Kochunov; David Glahn; Jack Lancaster; Anderson Winkler; Jack W Kent; Rene L Olvera; Shelley A Cole; Thomas D Dyer; Laura Almasy; Ravi Duggirala; Peter T Fox; John Blangero Journal: Stroke Date: 2010-08-19 Impact factor: 7.914
Authors: Katherine L Narr; Roger P Woods; Paul M Thompson; Philip Szeszko; Delbert Robinson; Teodora Dimtcheva; Mala Gurbani; Arthur W Toga; Robert M Bilder Journal: Cereb Cortex Date: 2006-11-21 Impact factor: 5.357
Authors: Tineke van Veen; Jessica Nielsen; Johannes Berkhof; Frederik Barkhof; Wouter Kamphorst; Lars Bö; Rivka Ravid; Cor L Verweij; Inge Huitinga; Chris H Polman; Bernard M J Uitdehaag Journal: J Neuroimmunol Date: 2007-09-19 Impact factor: 3.478
Authors: Madhav Thambisetty; Yang An; Anna Kinsey; Deepthi Koka; Muzamil Saleem; Andreas Güntert; Michael Kraut; Luigi Ferrucci; Christos Davatzikos; Simon Lovestone; Susan M Resnick Journal: Neuroimage Date: 2011-07-28 Impact factor: 6.556
Authors: Peter Kochunov; David C Glahn; Jack Lancaster; Anderson Winkler; Kathrin Karlsgodt; Rene L Olvera; Joanna E Curran; Melanie A Carless; Thomas D Dyer; Laura Almasy; Ravi Duggirala; Peter T Fox; John Blangero Journal: Hypertension Date: 2010-12-06 Impact factor: 10.190
Authors: K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale Journal: AJNR Am J Neuroradiol Date: 2010-01-14 Impact factor: 3.825
Authors: Aderbal R T Silva; Lea T Grinberg; Jose M Farfel; Breno S Diniz; Leandro A Lima; Paulo J S Silva; Renata E L Ferretti; Rafael M Rocha; Wilson Jacob Filho; Dirce M Carraro; Helena Brentani Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240
Authors: Yu-Han Chen; Breannan Howell; J Christopher Edgar; Mingxiong Huang; Peter Kochunov; Michael A Hunter; Cassandra Wootton; Brett Y Lu; Juan Bustillo; Joseph R Sadek; Gregory A Miller; José M Cañive Journal: Schizophr Bull Date: 2019-06-18 Impact factor: 9.306
Authors: Hayley F North; Jason Bruggemann; Vanessa Cropley; Vaidy Swaminathan; Suresh Sundram; Rhoshel Lenroot; Avril M Pereira; Andrew Zalesky; Chad Bousman; Christos Pantelis; Thomas W Weickert; Cynthia Shannon Weickert Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-03-24 Impact factor: 5.270
Authors: Jin Li; Qiushi Zhang; Feng Chen; Jingwen Yan; Sungeun Kim; Lei Wang; Weixing Feng; Andrew J Saykin; Hong Liang; Li Shen Journal: Biomed Res Int Date: 2015-09-03 Impact factor: 3.411
Authors: Szilárd Póliska; Timea Besenyei; Edit Végh; Attila Hamar; Anita Pusztai; Andrea Váncsa; Nóra Bodnár; Szilvia Szamosi; Mária Csumita; György Kerekes; Zoltán Szabó; Zoltán Nagy; Gabriella Szűcs; Sándor Szántó; Gábor Zahuczky; László Nagy; Zoltán Szekanecz Journal: Arthritis Res Ther Date: 2019-04-15 Impact factor: 5.156
Authors: Elena A Spieker; Peter Kochunov; Laura M Rowland; Emma Sprooten; Anderson M Winkler; Rene L Olvera; Laura Almasy; Ravi Duggirala; Peter T Fox; John Blangero; David C Glahn; Joanne E Curran Journal: Front Genet Date: 2015-02-13 Impact factor: 4.599